My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Travere Therapeutics, Inc. - Common Stock (NQ:TVTX)

35.21 +0.48 (+1.38%)

Streaming Delayed Price Updated: 2:55 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Travere Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

What's Going On With Travere Therapeutics Stock? ↗

December 05, 2023

Travere Therapeutics, Inc. (NASDAQ: TVTX) shares are trading higher Tuesday.

Via Benzinga

Travere Therapeutics Inc. (NASDAQ: TVTX) Near the Top of Equities by Percentage Gain on 12/5

December 05, 2023

Via Investor Brand Network

NIO Reports Q3 Results, Joins Hovnanian Enterprises, Signet Jewelers And Other Big Stocks Moving Higher On Tuesday ↗

December 05, 2023

U.S. stocks traded mostly lower, with the Dow Jones index falling more than 100 points on Tuesday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 04, 2023

Via Benzinga

Travere Completes Successful pre-NDA Meeting for FILSPARI in IgAN; Provides Regulatory Updates for both IgAN and FSGS

December 04, 2023

From Travere Therapeutics, Inc.

Via GlobeNewswire

Where Travere Therapeutics Stands With Analysts ↗

November 20, 2023

Via Benzinga

Preview: Travere Therapeutics's Earnings ↗

November 06, 2023

Via Benzinga

Travere Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference

November 21, 2023

From Travere Therapeutics, Inc.

Via GlobeNewswire

Travere Therapeutics Reports Third Quarter 2023 Financial Results

November 07, 2023

From Travere Therapeutics, Inc.

Via GlobeNewswire

Travere Therapeutics Announces Late-Breaking Data from Phase 3 Studies of Sparsentan in IgAN and FSGS Published in The Lancet and The NEJM Respectively and Presented at the American Society of Nephrology (ASN) Kidney Week 2023

November 03, 2023

From Travere Therapeutics, Inc.

Via GlobeNewswire

Expert Ratings for Travere Therapeutics ↗

September 22, 2023

Via Benzinga

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

Travere Therapeutics to Report Third Quarter 2023 Financial Results

October 24, 2023

From Travere Therapeutics, Inc.

Via GlobeNewswire

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023

October 13, 2023

From Travere Therapeutics, Inc.

Via GlobeNewswire

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 11, 2023

From Travere Therapeutics, Inc.

Via GlobeNewswire

Travere Therapeutics, Inc. (NASDAQ:TVTX) Shareholder Notice: Investigation over Possible Breaches of Fiduciary Duties ↗

September 29, 2023

San Diego, CA -- (SBWIRE) -- 09/29/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Travere Therapeutics, Inc.

Via SBWire

Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)

September 26, 2023

From Travere Therapeutics, Inc.

Via GlobeNewswire

Micron Technology To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Friday ↗

September 22, 2023

Loop Capital increased the price target for Splunk Inc. (NASDAQ: SPLK) from $135 to $157. Loop Capital analyst Yun Kim downgraded the stock from Buy to Hold. Splunk shares fell 0.1% to $144.25 in...

Via Benzinga

Back To Back Trial Failures: Analyst Weighs In On Travere Therapeutics' Prospects, Challenges ↗

September 21, 2023

William Blair downgraded Travere Therapeutics Inc (NASDAQ: TVTX)

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023 ↗

September 22, 2023

Via Benzinga

Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit ↗

September 21, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 200 points on Thursday. The Dow traded down 0.58% to 34,239.48 while the NASDAQ fell 1.20% to 13,307.77. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 21, 2023

Via Benzinga

Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 21, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.

Via Benzinga

Why Shares of Travere Therapeutics Are Slumping Thursday ↗

September 21, 2023

A mixed trial could hurt a kidney drug's chances of full approval.

Via The Motley Fool

Why Former Highflier Travere Therapeutics Just Crashed 41% To A Decade-Low ↗

September 21, 2023

It's now up to the FDA whether the company's key drug remains on the market.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Thursday ↗

September 21, 2023

During the session on Thursday, 461 stocks hit new 52-week lows.

Via Benzinga

Gold Down Over 1%; FedEx Shares Rise On Earnings Beat ↗

September 21, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones falling around 150 points on Thursday. The Dow traded down 0.46% to 34,284.15 while the NASDAQ fell 1.05% to 13,327.80. The S&P 500...

Via Benzinga

Topics Stocks

Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected ↗

September 21, 2023

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.56% to 34,248.45 while the NASDAQ fell...

Via Benzinga

Topics Stocks

Why Is Kidney-Disease Focused Travere Therapeutics Stock Trading Lower Today? ↗

September 21, 2023

Travere Therapeutics Inc (NASDAQ: TVTX) announced

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 21, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.